Your session is about to expire
← Back to Search
Other
Study of the TearCare System in Dry Eye Disease
N/A
Recruiting
Research Sponsored by Sight Sciences, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights
No Placebo-Only Group
Summary
This study is being conducted to evaluate the short-term (1 month) safety and effectiveness of a single TearCare procedure to treat adult patients with dry eye disease. NOTE: All sites have been selected for this study.
Eligible Conditions
- Dry Eye Syndrome
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Tear Break-up time from baseline to 1 month
Secondary study objectives
Change in Conjunctival staining score from baseline to 1 month
Change in Cornea staining score from baseline to 1 month
Change in Meibomian gland secretion score from baseline to 1 month
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: TearCareExperimental Treatment1 Intervention
All subjects in the study will undergo the TearCare procedure one time at the baseline visit. They will then be followed out to one month.
Find a Location
Who is running the clinical trial?
Sight Sciences, Inc.Lead Sponsor
13 Previous Clinical Trials
1,308 Total Patients Enrolled